Adverse drug reactions in hospitals: a narrative review.
暂无分享,去创建一个
Munir Pirmohamed | M. Pirmohamed | D. Mottram | E. C. Davies | C. F. Green | David R Mottram | Emma C Davies | Christophe F Green | Emma C. Davies
[1] K. Hartigan-Go,et al. Inclusion of therapeutic failures as adverse drug reactions , 2000 .
[2] David Classen,et al. Implementing Antibiotic Practice Guidelines through Computer-Assisted Decision Support: Clinical and Financial Outcomes , 1996, Annals of Internal Medicine.
[3] R. Tallis,et al. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. , 1992, Age and ageing.
[4] G. Aithal,et al. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications , 1999, The Lancet.
[5] I. Choonara,et al. Adverse drug reactions to unlicensed and off‐label drugs on paediatric wards: a prospective study , 1999, Acta paediatrica.
[6] S. Kong,et al. Characteristics Associated with Ability to Prevent Adverse Drug Reactions in Hospitalized Patients , 1998, Pharmacotherapy.
[7] M Pirmohamed,et al. Genetic susceptibility to adverse drug reactions. , 2001, Trends in pharmacological sciences.
[8] C. Simmons,et al. ADVERSE DRUG REACTIONS : CAN WE REDUCE THE RISK? , 1998 .
[9] Bengt Jönsson,et al. Pharmacoeconomics of adverse drug reactions , 2004, Fundamental & clinical pharmacology.
[10] A. Avery,et al. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study , 2003, Quality & safety in health care.
[11] L. Wienkers,et al. Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9. , 1994, Pharmacogenetics.
[12] N Hurwitz,et al. Intensive Hospital Monitoring of Adverse Reactions to Drugs , 1969, British medical journal.
[13] G Geisslinger,et al. Computerized survelliance of adverse drug reactions in hospital: pilot study. , 1998, British journal of clinical pharmacology.
[14] N. Moore,et al. Frequency and cost of serious adverse drug reactions in a department of general medicine. , 1998, British journal of clinical pharmacology.
[15] E. Roughead,et al. Drug‐related hospital admissions: a review of Australian studies published 1988‐1996 , 1998, The Medical journal of Australia.
[16] H. Beijer,et al. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies , 2002, Pharmacy World and Science.
[17] J. Gurwitz. Polypharmacy: a new paradigm for quality drug therapy in the elderly? , 2004, Archives of internal medicine.
[18] I. Olkin,et al. Adverse drug reactions in hospitalized patients: A critique of a meta-analysis. , 2000, MedGenMed : Medscape general medicine.
[19] J. Venulet,et al. Methods for monitoring and documenting adverse drug reactions. , 1996, International journal of clinical pharmacology and therapeutics.
[20] Claudio Pedone,et al. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. , 2005, Archives of internal medicine.
[21] D. Suh,et al. Clinical and Economic Impact of Adverse Drug Reactions in Hospitalized Patients , 2000, The Annals of pharmacotherapy.
[22] M. Pirmohamed,et al. Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study. , 2000 .
[23] R E Ferner,et al. Joining the DoTS: new approach to classifying adverse drug reactions , 2003, BMJ : British Medical Journal.
[24] P. Schneider,et al. Preventability and severity assessment in reporting adverse drug reactions. , 1992, American journal of hospital pharmacy.
[25] R. Tallis,et al. PRESCRIPTION OF CONTRAINDICATED AND INTERACTING DRUGS IN ELDERLY PATIENTS ADMITTED TO HOSPITAL , 1984, The Lancet.
[26] F. Gribnau,et al. Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward. , 1995, The Netherlands journal of medicine.
[27] D. Greenblatt,et al. A method for estimating the probability of adverse drug reactions , 1981, Clinical pharmacology and therapeutics.
[28] M. Cesari,et al. Adverse drug reactions and cognitive function among hospitalized older adults , 2002, European Journal of Clinical Pharmacology.
[29] U. Meyer. Pharmacogenetics and adverse drug reactions , 2000, The Lancet.
[30] G. Geisslinger,et al. Computerized surveillance of adverse drug reactions in hospital: Implementation , 1999, European Journal of Clinical Pharmacology.
[31] L. Bowman,et al. Incidence of adverse drug reactions in adult medical inpatients. , 1994, The Canadian journal of hospital pharmacy.
[32] L L Leape,et al. Preventing medical injury. , 1993, QRB. Quality review bulletin.
[33] G. Schumock,et al. Focusing on the preventability of adverse drug reactions. , 1992, Hospital pharmacy.
[34] D. Bates,et al. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. , 1997, Critical care medicine.
[35] D. Bates,et al. The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .
[36] M. Pirmohamed,et al. Which drugs cause preventable admissions to hospital? A systematic review. , 2007, British journal of clinical pharmacology.
[37] R F Moulds,et al. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs , 1996, The Medical journal of Australia.
[38] K. Gholami,et al. Factors Associated with Preventability, Predictability, and Severity of Adverse Drug Reactions , 1999, The Annals of pharmacotherapy.
[39] E. Sellers,et al. Effect of adverse drug reactions on the length of hospitalization. , 1978, American journal of hospital pharmacy.
[40] F. Follath,et al. Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. , 2000, British journal of clinical pharmacology.
[41] N. Laird,et al. Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .
[42] P. Routledge,et al. Adverse drug reactions in elderly patients. , 2003, British journal of clinical pharmacology.
[43] A. Laupacis,et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. , 2003, JAMA.
[44] J. Jones. Adverse drug reactions in the community health setting: approaches to recognizing, counseling, and reporting. , 1982, Family & community health.
[45] C. Pedone,et al. Socio-demographic factors related to the prevalence of adverse drug reaction at hospital admission in an elderly population. , 2005, Archives of gerontology and geriatrics.
[46] R. Schlienger,et al. Potential drug–drug interactions in the medication of medical patients at hospital discharge , 2003, European Journal of Clinical Pharmacology.
[47] G. Shenfield,et al. Health professionals rarely record history of complementary and alternative medicines. , 2005, British journal of clinical pharmacology.
[48] L. Cluff,et al. EPIDEMIOLOGICAL STUDIES OF ADVERSE DRUG REACTIONS. , 1965, American journal of public health and the nation's health.
[49] G. Wilkinson,et al. Drug metabolism and variability among patients in drug response. , 2005, The New England journal of medicine.
[50] M. Pirmohamed,et al. Adverse drug reactions: back to the future. , 2003, British journal of clinical pharmacology.
[51] Z. T. Grapes,et al. Factors associated with preventable adverse drug reactions. , 1994, American journal of hospital pharmacy.
[52] J. Doucet,et al. Drug‐Drug Interactions Related to Hospital Admissions in Older Adults: A Prospective Study of 1000 Patients , 1996, Journal of the American Geriatrics Society.
[53] P Impicciatore,et al. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. , 2001, British journal of clinical pharmacology.
[54] Michael J. Peters,et al. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. , 2003, Archives of internal medicine.
[55] M. Rawlins. Pathogenesis of adverse drug reactions , 1977 .
[56] Adverse Drug Reaction , 1998 .
[57] P. McDonnell. The $181,000 Adverse Drug Reaction , 2004 .
[58] C. George,et al. The effect of ageing on the hepatic clearance of propranolol. , 1979, British journal of clinical pharmacology.
[59] S. Roy,et al. Adverse drug reactions: an investigation on an acute geriatric ward. , 1986, Age and ageing.
[60] A. Chedid,et al. Aging Liver. A review. , 2002, Gerontology.
[61] S X Kong,et al. Estimating the rate of adverse drug reactions with capture-recapture analysis. , 1996, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[62] Stephen H. D. Jackson,et al. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. , 2003, British journal of clinical pharmacology.
[63] D. Bates,et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. , 1999, JAMA.
[64] R E Ferner,et al. Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. , 2001, British journal of clinical pharmacology.
[65] I. Edwards,et al. Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.
[66] L. Cluff,et al. STUDIES ON THE EPIDEMIOLOGY OF ADVERSE DRUG REACTIONS. I. METHODS OF SURVEILLANCE. , 1964, JAMA.
[67] J. Hallas,et al. Drug related events and drug utilization in patients admitted to a geriatric hospital department. , 1991, Danish medical bulletin.
[68] N. Laird,et al. Incidence of adverse drug events and potential adverse drug events , 1995 .
[69] J. Schwartz. The Influence of Sex on Pharmacokinetics , 2003, Clinical pharmacokinetics.
[70] R. Ogilvie,et al. Adverse drug reactions during hospitalization. , 1967, Canadian Medical Association journal.
[71] D. Roden. Drug-induced prolongation of the QT interval. , 2004, The New England journal of medicine.
[72] Julia K. Nguyen,et al. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. , 2006, The American journal of geriatric pharmacotherapy.
[73] P. Corey,et al. Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .
[74] A. W. Lenderink,et al. Risk factors for the development of adverse drug events in hospitalized patients , 2000, Pharmacy World and Science.
[75] Medication histories: does anyone know what medicines a patient should be taking? , 2004 .
[76] M. Lapeyre-Mestre,et al. Adverse drug reactions and off-label drug use in paediatric outpatients. , 2002, British journal of clinical pharmacology.
[77] E. Schimmel. The hazards of hospitalization* , 2003, Annals of internal medicine.
[78] C. Vincent,et al. Causes of prescribing errors in hospital inpatients: a prospective study , 2002, The Lancet.
[79] D. Luscombe,et al. Patients' knowledge and perceptions of the side‐effects of OTC medication , 2002, Journal of clinical pharmacy and therapeutics.
[80] A. Egberts,et al. Adverse drug events in hospitalized patients A comparison of doctors, nurses and patients as sources of reports , 1999, European Journal of Clinical Pharmacology.
[81] W. Mcbride,et al. Thalidomide and Congenital Abnormalities , 1961 .
[82] Roberto Bernabei,et al. Is Age an Independent Risk Factor of Adverse Drug Reactions in Hospitalized Medical Patients?* , 1991, Journal of the American Geriatrics Society.
[83] Russ B Altman,et al. Challenges for biomedical informatics and pharmacogenomics. , 2002, Annual review of pharmacology and toxicology.
[84] E. Hahn,et al. Implementation of a computer‐assisted monitoring system for the detection of adverse drug reactions in gastroenterology , 2004, Alimentary pharmacology & therapeutics.
[85] R S Evans,et al. Preventing Adverse Drug Events in Hospitalized Patients , 1994, The Annals of pharmacotherapy.
[86] L. Cluff,et al. Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility. , 1966, Annals of internal medicine.
[87] J. Hallas,et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention , 1990, Journal of internal medicine.
[88] E. Vargas,et al. Effect of adverse drug reactions on length of stay in surgical intensive care units , 2003, Critical care medicine.
[89] M. Lehmann,et al. JTc prolongation with d,l-sotalol in women versus men. , 1999, The American journal of cardiology.
[90] H. Jick,et al. Drug monitoring of surgical patients. , 1982, JAMA.
[91] P. Waller,et al. Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database. , 2005, British journal of clinical pharmacology.
[92] M. Pirmohamed,et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.